Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Pili

Showing results (11-20 of 223) with videos related to

Pageof 23
Sort By:
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Posttranscription regulation of prostate cancer growthLi Shen, Roberto Pili
Oncoimmunology|October 25, 2019
Tasquinimod targets suppressive myeloid cells in the tumor microenvironmentLi Shen, Roberto Pili
Geriatrics (Basel, Switzerland)|May 3, 2020
Ageing and COVID-19: What is the Role for Elderly People?Donatella Rita Petretto, Roberto Pili
Journal of the National Cancer Institute|April 3, 2003
Is HIF-1 alpha a valid therapeutic target?Roberto Pili, Ross C Donehower
Geriatrics (Basel, Switzerland)|June 1, 2022
Ageing and Disability According to the Perspective of Clinical Psychology of DisabilityDonatella R Petretto, Roberto Pili
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2012
Mind the gap: potential for rebounds during antiangiogenic treatment breaksJohn M L Ebos, Roberto Pili
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2013
Major response to cyclophosphamide and prednisone in recurrent castration-resistant prostate cancerNicolas Batty, Naveen Yarlagadda, Roberto Pili
Epigenomics|July 31, 2013
Histone modifications: implications in renal cell carcinomaSwathi Ramakrishnan, Leigh Ellis, Roberto Pili
Clinical Genitourinary Cancer|January 24, 2017
Unclassified Renal Cell Carcinoma With Significant Response to NivolumabNabil Adra, Liang Cheng, Roberto Pili
Clinical Advances in Hematology & Oncology : H&O|December 17, 2011
Resistance to angiogenesis inhibitors in renal cell carcinomaIla Tamaskar, Jaspreet Dhillon, Roberto Pili
Pageof 23

Showing results (11-20 of 223) with videos related to

Sort By:
Pageof 23
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Posttranscription regulation of prostate cancer growthLi Shen, Roberto Pili
Oncoimmunology|October 25, 2019
Tasquinimod targets suppressive myeloid cells in the tumor microenvironmentLi Shen, Roberto Pili
Geriatrics (Basel, Switzerland)|May 3, 2020
Ageing and COVID-19: What is the Role for Elderly People?Donatella Rita Petretto, Roberto Pili
Journal of the National Cancer Institute|April 3, 2003
Is HIF-1 alpha a valid therapeutic target?Roberto Pili, Ross C Donehower
Geriatrics (Basel, Switzerland)|June 1, 2022
Ageing and Disability According to the Perspective of Clinical Psychology of DisabilityDonatella R Petretto, Roberto Pili
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2012
Mind the gap: potential for rebounds during antiangiogenic treatment breaksJohn M L Ebos, Roberto Pili
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2013
Major response to cyclophosphamide and prednisone in recurrent castration-resistant prostate cancerNicolas Batty, Naveen Yarlagadda, Roberto Pili
Epigenomics|July 31, 2013
Histone modifications: implications in renal cell carcinomaSwathi Ramakrishnan, Leigh Ellis, Roberto Pili
Clinical Genitourinary Cancer|January 24, 2017
Unclassified Renal Cell Carcinoma With Significant Response to NivolumabNabil Adra, Liang Cheng, Roberto Pili
Clinical Advances in Hematology & Oncology : H&O|December 17, 2011
Resistance to angiogenesis inhibitors in renal cell carcinomaIla Tamaskar, Jaspreet Dhillon, Roberto Pili
Pageof 23